Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
The Lancet. Digital Health|May 21, 2023
Development, multi-institutional external validation, and algorithmic audit of an artificial intelligence-based Side-specific Extra-Prostatic Extension Risk Assessment tool (SEPERA) for patients undergoing radical prostatectomy: a retrospective cohort studyJethro C C Kwong, Adree Khondker, Eric Meng, et al.
Bladder Cancer (Amsterdam, Netherlands)|August 12, 2024
Multi-Center Assessment of Lymph-Node Density and Nodal-Stage to Predict Disease-Specific Survival in Patients with Bladder Cancer Treated by Radical CystectomyErik J van Gennep, Francesco Claps, Peter J Bostrom, et al.
International Journal of Cancer|October 24, 2018
Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancerRicardo Leão, Donghyun Lee, Arnaldo Figueiredo, et al.
The Lancet. Oncology|May 15, 2023
Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysisAlexandre R Zlotta, Leslie K Ballas, Andrzej Niemierko, et al.
European Urology|October 8, 2025
Development and International Evaluation of an Artificial Intelligence-based Model (PROGRxN-BCa) Using the World Health Organization 2004/2022 Grading System to Predict Progression Risk and Improve Substratification for Non-muscle-invasive Bladder CancerJethro C C Kwong, Zizo Al-Daqqaq, Yashan Chelliahpillai, et al.
BJU International|February 7, 2023
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomyFrancesco Claps, Maaike W van de Kamp, Roman Mayr, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 15, 2024
Proportion of Gleason Score ≥8 Prostate Cancer on Biopsy and Tumor Aggressiveness in Matched Cohorts of East Asian and Non-East Asian MenLiang Dong, Katherine Lajkosz, Rafael Sanchez-Salas, et al.
European Urology|July 20, 2020
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†Bas W G van Rhijn, Laura S Mertens, Roman Mayr, et al.
Urologic Oncology|December 15, 2021
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patientsLaura S Mertens, Francesco Claps, Roman Mayr, et al.
Urologic Oncology|November 10, 2019
Papillary urothelial neoplasm of low malignant potential (PUN-LMP): Still a meaningful histo-pathological grade category for Ta, noninvasive bladder tumors in 2019?Anouk E Hentschel, Bas W G van Rhijn, Johannes Bründl, et al.
Pageof 17